HHS Secretary Robert F. Kennedy Jr. said the effort will support patient autonomy, informed consent, and what he described as a more holistic approach to mental health care.
For anyone researching mental health treatment options, the announcement signals a shift toward emphasizing nonmedication interventions such as therapy, family support, dietary changes and physical activity, alongside continued medication use where appropriate.
What the Plan Actually Does
According to HHS, several federal agencies will work together to evaluate prescription patterns for psychiatric medications, weigh their benefits and potential harms and elevate non-medication treatments.
The department said its approach includes education and outreach, policy actions and efforts to help research inform clinical practice.
Overprescribing, in this context, refers to prescribing medication to patients who may not need it based on symptom severity or without first trying other interventions.
Deprescribing means discontinuing a medication treatment that is not working and replacing it with a more effective option, according to Dr. Joseph F. Goldberg, a clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai.
Support and Concerns From Psychiatry Experts
Reaction from psychiatry professionals has been mixed. Dr. Theresa Miskimen Rivera, president of the American Psychiatric Association, said the group supports additional investment, research, and clinical training.
At the same time, she raised concerns about framing mental health primarily as a problem of overmedicalization, calling that characterization an oversimplification of a complex issue.
Other experts pointed to a different problem entirely: limited access to mental health treatment in the first place. Dr. Jonathan Alpert, chair of psychiatry and behavioral sciences at Montefiore Medical Center, said psychiatric medications, like other medications, can be both overprescribed and underprescribed, and that either extreme carries risk.
Goldberg noted that depression remains the leading cause of disability worldwide, yet only about 40% of adults and adolescents with depression in the United States received individual counseling or therapy in recent years, and just 11.4% took prescription medication for depression. He also cited data showing suicide rates rose 35% between 2000 and 2018.
Rivera said mental health care access remains unevenly distributed nationally, citing workforce shortages, limited psychiatric beds, short visit times, and barriers to psychotherapy as ongoing obstacles that a focus on overprescribing alone does not address.
Where the Debate Stands
Supporters of the plan argue that some patients are prescribed psychiatric drugs longer than necessary or without adequate consideration of nonmedication alternatives, and that added transparency and shared decision-making could reduce unnecessary use.
Critics counter that spotlighting overprescribing risks discouraging appropriate medication use and distracts from the more urgent problem of millions of people who cannot access any mental health treatment at all.
Both sides agree that abruptly stopping a psychiatric medication without medical supervision carries real risk. Rivera emphasized that quitting medication on one’s own can trigger side effects or a return of the original condition.
She urged patients with concerns about a current prescription to raise those concerns with their physician rather than stop treatment independently.
What This Means for Treatment Seekers
Anyone currently taking a psychiatric medication, or considering starting one, should treat this announcement as a reason to have a conversation with a prescriber rather than to make changes independently.
The federal plan does not change existing prescriptions or FDA safety determinations, which classify antidepressants and other psychiatric medications as generally safe and effective for conditions including depression, anxiety and substance use disorder.
For families weighing mental health treatment for a child, the plan’s emphasis on informed consent and shared decision-making may mean more conversation with providers about medication timelines, nonmedication options, and periodic review of whether a given prescription is still the right fit.
Exploring Treatment Options
People navigating a mental health treatment decision, whether for themselves or a family member, can take a few concrete steps:
- Ask a prescriber to walk through the reasoning behind a specific medication, including expected benefits, timeline, and alternatives.
- Request a periodic medication review rather than assuming a prescription is permanent.
- Explore integrated care options that combine therapy, medication management, and support for co-occurring substance use where relevant.
- Verify what a treatment center’s insurance and payment options cover before starting care.
Rehab.com’s directory helps people compare treatment centers that offer integrated mental health and substance use care, including options for medication management alongside therapy. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment specialist.
